Suddenly, the spring breeze comes, AI+ is everywhere, and AI+ Medical has become an area where giants and innovative companies compete for layout.
Baidu launched the Baidu medical brain in October 2016, officially applying artificial intelligence technology to the medical and health industry. Medical health is Baidu's most important vertical field; Ali is starting to adopt the form of contract with hospitals to promote smart medical care from 2017. And relying on the massive user base of the entire Ali system, such as Tmall, Taobao, etc., to establish a health management platform; Tencent's AI medical solution "Tencent Shadow" has released the colorectal cancer screening AI system and early esophageal cancer screening AI system .
If there is demand, there will be a market. The reason why BAT spares no expense to invest in artificial intelligence medical field is because China’s objective reality has urgent needs for artificial intelligence medical treatment. First, the huge population makes the supply of high-quality medical resources in China insufficient and the cost is high. Secondly, Doctors have a long training period, but the disease spectrum changes rapidly, and the technology changes with each passing day, resulting in a high rate of misdiagnosis. Finally, as the population ages, chronic diseases grow, and people pay more attention to health, the demand for medical services will only continue to increase.
So, based on the current state of the art, which medical fields have artificial intelligence been applied to?
The first mature field of artificial intelligence application is medical image analysis. Because the image itself is structured, there is no human factor interference, and it can be quickly and accurately analyzed by artificial intelligence. Secondly, medical big data can turn unstructured into Structured data, through the analysis of a large number of medical records to find better treatment options, better management of the disease, there are many companies are currently conducting related research; finally, a variety of auxiliary medical robots have also sprung up, and rapid development.
With the initial results of the application of artificial intelligence in the medical and health field, the urgent problems facing the whole industry have also been exposed: the mature profit model has not yet been formed, which is the biggest obstacle to the comprehensive landing of artificial intelligence medical treatment. How is AI+ medical products commercialized? How is the entire industry industrialized? It is an issue that needs to be explored and solved in the industry.
On August 31, 2018, Dou Yumei, Senior Director of Yitu Medical, will share his keynote speech at the “OFweek (2nd) China Artificial Intelligence Industry Conference – AI+ Medical Forum†. The Industrialization Process and Prospect of AI Medical in Exploration 》, to explore the role of AI medical, landing practice and product commercialization, industry industrialization to explore new knowledge, and industry outlook.
Dou Yumei graduated from Shanghai Jiaotong University with a degree in Electrical Engineering. He received an MBA from Fudan University School of Management and Norwegian BI Business School. He has more than 10 years of experience in product, marketing and corporate management in enterprise software, Saas software services, and mobile Internet applications. He has created a mobile internet scene marketing company. After 2016, he joined Etu Technology, deepened in the field of artificial intelligence security and medical treatment, explored the forefront of industry technology development and application, and carried out 0-1 business practice.
For details of the event and registration, please click: "OFweek (2nd) China Artificial Intelligence Industry Conference - AI+ Medical Forum"
Remarks:
1. OFweek member welfare ticket, join the welfare group to participate in promotion and sharing, you will have the opportunity to get a 1,500 yuan conference pass!
2, in order to support scientific research, research institutes and students can enjoy a 50% discount (subject to the unit seal or student certification materials).
3, 5 or more people participate in the booking to enjoy a 30% discount, please contact the organizing committee directly.
4. Due to the large number of participants at the conference, in order to provide better services to registered visitors, all closed-door conferences do not accept temporary ticket sales. Please ask the audience who need to participate in the application in advance. The registration time for the conference ends on August 28. When the audience reports on the spot, they can enter the venue with the confirmation code and business card. Audiences who have not confirmed their registration in advance will not be accepted at the scene.
5. For more information, please contact:
China Extract Powder For Use As Dietary Supplement Extract Powder, Extract Powder Manufacturer
Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.anabolicsteriod.com